The role of interferon-gamma and its signaling pathway in pediatric hematological disorders

Medicine and Dentistry

• Gamma Interferon 100%
• Hemophagocytic Syndrome 57%
• Combination Therapy 28%
• Neutralization 28%
• Aplastic Anemia 28%
• Intracellular Signaling 28%
• Sulfhemoglobinemia 14%
• Pathophysiology 14%
• Receptor 14%
• Signal Transduction 14%
• Monoclonal Antibody 14%
• Binding Site 14%
• Graft Failure 14%
• Thrombopoietin 14%
• Hematopoiesis 14%
• Allogeneic Hematopoietic Stem Cell Transplantation 14%
• Eltrombopag 14%
• Ruxolitinib 14%
• Chimeric Antigen Receptor T-Cell 14%
• Therapeutic Procedure 14%
• Pediatrics 14%
• Inpatient 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Gamma Interferon 100%
• Hemophagocytic Syndrome 57%
• Aplastic Anemia 28%
• Agonist 28%
• Pathophysiology 14%
• Binding Site 14%
• Receptor 14%
• Graft Failure 14%
• Hematologic Disease 14%
• Monoclonal Antibody 14%
• Thrombopoietin 14%
• Eltrombopag 14%
• Ruxolitinib 14%
• Emapalumab 14%

Immunology and Microbiology

• Interferon Gamma 100%
• Hemophagocytic Lymphohistiocytosis 57%
• Aplastic Anemia 28%
• Signal Transduction 14%
• Electric Potential 14%
• Monoclonal Antibodies 14%
• Binding Site 14%
• Hematopoiesis 14%
• Agonist 14%
• Allogeneic Hematopoietic Stem Cell Transplantation 14%
• Chimeric Antigen Receptor T-Cell 14%
• Molecule 14%
• Thrombopoietin 14%
• Emapalumab 14%